Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05031338 · ClinicalTrials.gov registry record
Carpal Tunnel Release Using Ultrasound
A clinical trial, sponsored by Sonex Health.
- Terminated
- Registry status
- 411
- Enrollment target
NCT05031338: Clinical Trial study, sponsored by Sonex Health.
NCT05031338 is a clinical trial that was terminated before completion, run by Sonex Health. The registered enrollment target is 411 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05031338 was terminated before completion, sponsored by Sonex Health.
- TERMINATED
- Registry status
- 411 participants
- Enrollment target
Study Summary
The goal of the Carpal Tunnel Release Using Ultrasound registry (CiTRUS Registry) is to collect experience information from patients scheduled to undergo carpal tunnel release surgery with either the SX-One MicroKnife® with ultrasound guidance or the traditional mini-open technique without US guidance.
Primary Outcome
To assess the overall patient experience following carpal tunnel release using either the SX-One MicroKnife® with ultrasound (US) guidance or the traditional mini-open technique without ultrasound guidance patients will complete the Quick Form of the Disabilities of the Shoulder and Hand scale. The Quick Form of the Disabilities of the Shoulder and Hand scale consists of 11 items scored 1-5 with lower scores indicating less symptoms or better function.
Interventions
- PROCEDURE Carpal Tunnel Release
- DEVICE Carpal Tunnel Release
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 411 participants |
| Start Date | 2021-07-02 |
| Est. Completion | 2022-08-15 |
Why NCT05031338 stopped before completion
NCT05031338 is an observational study that tracks outcomes without assigning an intervention. The registered 411 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Carpal Tunnel Release is the first listed.
NCT05031338 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05031338 about?
NCT05031338 is a clinical study titled "Carpal Tunnel Release Using Ultrasound". The goal of the Carpal Tunnel Release Using Ultrasound registry (CiTRUS Registry) is to collect experience information from patients scheduled to undergo carpal tunnel release surgery with either the SX-One MicroKnife® with ultrasound guidance or the traditional mini-open technique without US guidan...
What is the current status of trial NCT05031338?
This trial is currently terminated. The enrollment target is 411 participants. The study started on 2021-07-02. Estimated completion is 2022-08-15.
What interventions are being tested in trial NCT05031338?
The interventions under investigation include: Carpal Tunnel Release (PROCEDURE), Carpal Tunnel Release (DEVICE).
Who is sponsoring clinical trial NCT05031338?
This trial is sponsored by Sonex Health, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05993689 · 412 participants · NA
Building TrUst and UNiting Teams Through DouLa partnErship - BUNDLE
- NCT06699212 · 412 participants · Phase 3
A Study of ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab in First-line Treatment of Locoregional Recurrent Squamous Cell Carcinoma of the Head and Neck With No Distant Metastases
- NCT02043691 · 410 participants · NA
Evaluation of the Cook Custom Aortic Endograft, the Zenith t-Branch Endovascular Graft, and Surgeon-Modified Endograft in Treating Aortic Pathologies
- NCT03042975 · 410 participants
Imaging Genetics of Laryngeal Dystonia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI